EPISODE · May 30, 2022 · 23 MIN
GSK Committed To Patient Outcomes
from The Breakfast Grille · host BFM Media
GSK will split into two new companies in 2022, they are GSK and Haleon. So what does this spin-off mean for Malaysia and the healthcare industry? Philip See speaks to Dr. Jonathan Pan, Vice President and GM of Malaysia and Brunei at GSK about their top-selling drugs, their role in the Covid-19 pandemic, and can Malaysia be a vaccine manufacturing hub? See omnystudio.com/listener for privacy information.
NOW PLAYING
GSK Committed To Patient Outcomes
No transcript for this episode yet
Similar Episodes
No similar episodes found.